U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 564/192 - Substituent Q is acyclic


Subclass of Class 564 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the carboxylic acid residue does not contain
No. of patents: 195
Last issue date: 05/29/2012


1          
NumberTitleIssue Date
8188313Analogs of alpha galactosylceramide and uses thereof
Compounds of formula wherein the variable are defined in the specification, are used in compositions which stimulate T cell responses. ...
05/29/2012
8101801Low molecular weight quaternary ammonium salt dispersants
Disclosed is a chemical compound having the structure: wherein R1 is an all group, aryl group, alkylaryl group or arylalkyl group with at least 23 carbon atoms, R2 is an alkylene group, arylene group, ...
01/24/2012
8097760Preparation of chiral amides and amines
This invention provides a convenient method for converting oximes into enamides. The process does not require the use of metallic reagents. Accordingly, it produces the desired compounds without the concomitant production of a large volume of metallic waste. The ena...
01/17/2012
8049038Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses
This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutically-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory dis...
11/01/2011
8039670Analogs of alpha galactosyceramide and uses thereof
There are disclosed compound of formula I, in which R1 represents a hydrophobic moiety adapted to occupy the C′ channel of human CDId, R2 represents a hydrophobic moiety adapted to occupy the A′ channel of human CDId, such that R1
10/18/2011
7977511Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses
This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutically-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory dis...
07/12/2011
7847123Antimicrobial compositions
Compounds of the general formula and to the use thereof for controlling microorganisms are provided. ...
12/07/2010
RE41135Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme
The present invention relates to compounds that are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for treatment of non-insuli...
02/16/2010
7439394Cyclohexyl-1,4-diamine compounds
Novel cyclohexyl-1,4-diamine compounds corresponding to formula I, processes for the production thereof, pharmaceutical compositions containing these compounds, methods of producing pharmaceutical compositions including the...
10/21/2008
7423177Carboxamide derivatives as therapeutic agents
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the...
09/09/2008
7358396Preparation of optically active amines
A process for preparing optically active amines, a process for preparing racemic amines which can be resolved using optically active carboxylic acids or enzymes, and racemic and optically active amines and optically active amides are described. ...
04/15/2008
7348457Ketol fatty acid derivatives and plant growth regulators
α-Ketol unsaturated fatty acid derivatives represented by the following formula (1), α-ketol unsaturated fatty acid amide derivatives represented by the following formula (6), and plant growth regulators containing, as the active ingredient, at least one of these ...
03/25/2008
7342131Levodopa prodrugs, and compositions and uses thereof
Prodrugs of levodopa, methods of making prodrugs of levodopa, methods of using prodrugs of levodopa, and compositions of prodrugs of levodopa are disclosed. ...
03/11/2008
7323608Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
One aspect of the present invention relates to copper-catalyzed carbon-heteroatom and carbon-carbon bond-forming methods. In certain embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-sulfur bond between the sulfur atom of a t...
01/29/2008
7307191Organic peroxyacid precursors
This present invention provides materials for use as solid or concentrated chemical precursors for the production of organic peroxy acids (peracids). Organic peroxy acids are formed using a precursor according to the invention when they are combined with hydrogen pe...
12/11/2007
7276613Retro-anandamides, high affinity and stability cannabinoid receptor ligands
Novel retro-anandamides are presented which have high affinities for the cannabinoid CB1 and/or CB2 receptor sites. Further, most of the analogs exhibit greater metabolic stability than arachidonylethanolamide. The improved receptor affinity and selectivity and/or g...
10/02/2007
7253282Hexafluoroisopropanol substituted cyclohexane derivatives
The invention is concerned with novel hexafluoroisopropanol substituted cyclohexane derivatives of formula (I) wherein R1 to R4, X, m and n are as defined in the description and in the claim...
08/07/2007
7230018Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
Substituted propane-1,3-diamine derivatives, methods for producing such derivatives, and medicaments and pharmaceutical compositions containing such derivatives useful for the treatment or prophylaxis of pain, urinary incontinence, itching, tinitus aurium, or diarrh...
06/12/2007
7217845Bifunctional polyethylene glycol derivatives
The present invention provides novel heterobifunctional and monobifunctional polyethylene glycol derivatives for the pegylation of therapeutically active proteins. The heterobifunctional PEGs which bear two different functional groups as well as the monobifunctional...
05/15/2007
7217838Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
The present invention relates to compounds that are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-in...
05/15/2007
7201876Ion-detecting sensors comprising plasticizer-free copolymers
Ion-detecting sensors for detecting a target ion in a sample are provided. The sensor comprises a plasticizer-free copolymer comprised of polymerized units of methacrylate monomers having pendent alkyl groups of different length and a functionalized ionophore of sai...
04/10/2007
7196119Development of new selective estrogen receptor modulators
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclos...
03/27/2007
7161016Cannabimimetic lipid amides as useful medications
Novel analogs of arachidonylethanolamide are presented which have higher affinities for the cannabinoid CB1 and/or CB2 receptor sites. Further, most of the analogs exhibit greater metabolic stability than arachidonylethanolamide. The improved receptor affinity and s...
01/09/2007
7161035Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
The invention relates to compounds of formula (I): wherein: B represents a hydrogen atom, a COOR group, a CONRR′ group, or a (C1–C6)alkyl group substit...
01/09/2007
7067471Process for producing a refined product of polyoxyproylene fatty acid isopropanolamide surfactant
A refined product of a polyoxypropylene fatty acid isopropanolamide surfactant, having a high stability in storage and a very small change in smell thereof, is obtained by heat-treating an addition-reaction mixture prepared from a compound of the formula (III) and p...
06/27/2006
7041855Monofunctional polyethylene glycol aldehydes
The present invention provides novel monofunctional polyethylene glycol aldehydes for the pegylation of therapeutically active proteins. The pegylated protein conjugates that are produced, retain a substantial portion of their therapeutic activity and are less immun...
05/09/2006
7015352Pro drugs for selective drug delivery
Prodrug compounds capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced. ...
03/21/2006
7015349Reduction of hair growth
Compositions including a conjugate of α-difluoromethylornithine can be applied topically to reduce hair growth. ...
03/21/2006
7005549Peracid precursors for antimicrobial use
This disclosure describes unique chemical structures for use as solid or concentrated chemical precursors to the production of peroxy acids when combined with hydrogen peroxide or a hydrogen peroxide precursor such as percarbonates or perborates. Peroxy acids (perac...
02/28/2006
6962693Alkylpolypropyleneoxide amidotriamines and method of using same
Alkylpolypropyleneoxide amidotriamines having antimicrobial activity are described. The compounds are useful as antimicrobial preservatives in various types of pharmaceutical compositions. Ophthalmic compositions containing these compounds as disinfecting agents or ...
11/08/2005
6956014Thickener
A thickener which is superior in handling characteristics and blending stability and has a high thickening action is provided, comprising a fatty acid alkanolamide represented by the general formula (1) and a surfactant composition comprising the thickener and at le...
10/18/2005
6884911Material processing by repeated solvent expansion-contraction
A method for repeatedly converting a solvent from a state of solvent to a state of antisolvent with relatively little loss of solvent. The method is used to allow for processing of large amounts of solute material with minimum amounts of solvent. ...
04/26/2005
6864386Fluorinated compounds
Fluorinated compounds and emulsions including the compounds. The compositions are useful as oxygen carriers and surfactants. In one embodiment, the fluorinated compound is pH sensitive. In one embodiment, the fluorinated compound is a vitamin E derivative. In one em...
03/08/2005
6770754Universal supports for oligonucleotide synthesis
Universal supports for oligonucleotide synthesis include a support material represented by the following formula: In this formula, substituent A is selected from H, alkyl, aryl, or a polymeric or silica base material; su...
08/03/2004
6767925Sprayable analgesic composition and method of use
A sprayable analgesic composition containing an analgesic which is absorbed into the bloodstream through the buccal mucosa and a pharmacologically acceptable liquid carrier. ...
07/27/2004
6759554Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
The present invention relates to copper-catalyzed carbon-heteroatom and carbon-carbon bond-forming methods. In certain embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-nitrogen bond between the nitrogen atom of an amide or a...
07/06/2004
RE38506Potent inducers of terminal differentiation and methods of use thereof
The present invention provides the compound having the structure: wherein each of R1 and R2 are independently the same as or different from each other; when R1 and R2 are the same, each i...
04/20/2004
6696494଱-hydroxyarylbutanamine inhibitors of aspartyl protease
Acylated ଱-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds. The compounds have the formula: ##STR1#...
02/24/2004
6630509Phenalkyloxy-phenyl derivatives
The present invention relates to certain phenalkyloxy-phenyl derivatives of formula (I) ##STR1## and analogs, to a process for preparing such compounds, which compounds have utility in treating clinical conditions associated with insulin resistance, ...
10/07/2003
6603043Process for the preparation of (schiff bases of) ଱-alkyl-଱-amino acid amides
Process for the preparation of a Schiff base of an ଱-alkyl-଱-amino acid amide and an aldehyde, wherein the corresponding ଱-aminonitrile is contacted with a base and the aldehyde and wherein it is ensured that the reagents are in good con...
08/05/2003
1          
 
Sign InRegister
Username  
Password   
forgot password?